Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival.
Delyon J, Mateus C, Lefeuvre D, Lanoy E, Zitvogel L, Chaput N, Roy S, Eggermont AM, Routier E, Robert C. Delyon J, et al. Among authors: routier e. Ann Oncol. 2013 Jun;24(6):1697-703. doi: 10.1093/annonc/mdt027. Epub 2013 Feb 24. Ann Oncol. 2013. PMID: 23439861 Free article.
Vemurafenib and radiosensitization.
Boussemart L, Boivin C, Claveau J, Tao YG, Tomasic G, Routier E, Mateus C, Deutsch E, Robert C. Boussemart L, et al. Among authors: routier e. JAMA Dermatol. 2013 Jul;149(7):855-7. doi: 10.1001/jamadermatol.2013.4200. JAMA Dermatol. 2013. PMID: 23699661
Kidney injuries related to ipilimumab.
Izzedine H, Gueutin V, Gharbi C, Mateus C, Robert C, Routier E, Thomas M, Baumelou A, Rouvier P. Izzedine H, et al. Among authors: routier e. Invest New Drugs. 2014 Aug;32(4):769-73. doi: 10.1007/s10637-014-0092-7. Epub 2014 Apr 1. Invest New Drugs. 2014. PMID: 24687600
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.
Boussemart L, Malka-Mahieu H, Girault I, Allard D, Hemmingsson O, Tomasic G, Thomas M, Basmadjian C, Ribeiro N, Thuaud F, Mateus C, Routier E, Kamsu-Kom N, Agoussi S, Eggermont AM, Désaubry L, Robert C, Vagner S. Boussemart L, et al. Among authors: routier e. Nature. 2014 Sep 4;513(7516):105-9. doi: 10.1038/nature13572. Epub 2014 Jul 27. Nature. 2014. PMID: 25079330
[Immunotherapies and melanoma].
Routier É, Robert C, Mateus C. Routier É, et al. Bull Cancer. 2014 Dec;101 Suppl 2:S13-24. doi: 10.1684/bdc.2014.2054. Bull Cancer. 2014. PMID: 25776763 Review. French.
Metastatic melanoma: New paradigms of treatment and new toxicities.
Robert C, Mateus C, Routier E, Thomas M, Boussemart L, Eggermont AM. Robert C, et al. Among authors: routier e. EJC Suppl. 2013 Sep;11(2):278-80. doi: 10.1016/j.ejcsup.2013.07.046. EJC Suppl. 2013. PMID: 26217144 Free PMC article. Review. No abstract available.
63 results